Cargando…
Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan
Tracking temporal and spatial genomic changes and evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are among the most urgent research topics worldwide, which help to elucidate the coronavirus disease 2019 (COVID-19) pathogenesis and the effect of deleterious variants. Ou...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236271/ https://www.ncbi.nlm.nih.gov/pubmed/35759503 http://dx.doi.org/10.1371/journal.pone.0270314 |
_version_ | 1784736494178533376 |
---|---|
author | Abdullaev, Alisher Abdurakhimov, Abrorjon Mirakbarova, Zebinisa Ibragimova, Shakhnoza Tsoy, Vladimir Nuriddinov, Sharofiddin Dalimova, Dilbar Turdikulova, Shahlo Abdurakhmonov, Ibrokhim |
author_facet | Abdullaev, Alisher Abdurakhimov, Abrorjon Mirakbarova, Zebinisa Ibragimova, Shakhnoza Tsoy, Vladimir Nuriddinov, Sharofiddin Dalimova, Dilbar Turdikulova, Shahlo Abdurakhmonov, Ibrokhim |
author_sort | Abdullaev, Alisher |
collection | PubMed |
description | Tracking temporal and spatial genomic changes and evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are among the most urgent research topics worldwide, which help to elucidate the coronavirus disease 2019 (COVID-19) pathogenesis and the effect of deleterious variants. Our current study concentrates genetic diversity of SARS-CoV-2 variants in Uzbekistan and their associations with COVID-19 severity. Thirty-nine whole genome sequences (WGS) of SARS-CoV-2 isolated from PCR-positive patients from Tashkent, Uzbekistan for the period of July-August 2021, were generated and further subjected to further genomic analysis. Genome-wide annotations of clinical isolates from our study have revealed a total of 223 nucleotide-level variations including SNPs and 34 deletions at different positions throughout the entire genome of SARS-CoV-2. These changes included two novel mutations at the Nonstructural protein (Nsp) 13: A85P and Nsp12: Y479N, which were unreported previously. There were two groups of co-occurred substitution patterns: the missense mutations in the Spike (S): D614G, Open Reading Frame (ORF) 1b: P314L, Nsp3: F924, 5`UTR:C241T; Nsp3:P2046L and Nsp3:P2287S, and the synonymous mutations in the Nsp4:D2907 (C8986T), Nsp6:T3646A and Nsp14:A1918V regions, respectively. The “Nextstrain” clustered the largest number of SARS-CoV-2 strains into the Delta clade (n = 32; 82%), followed by two Alpha-originated (n = 4; 10,3%) and 20A (n = 3; 7,7%) clades. Geographically the Delta clade sample sequences were grouped into several clusters with the SARS-CoV genotypes from Russia, Denmark, USA, Egypt and Bangladesh. Phylogenetically, the Delta isolates in our study belong to the two main subclades 21A (56%) and 21J (44%). We found that females were more affected by 21A, whereas males by 21J variant (χ2 = 4.57; p ≤ 0.05, n = 32). The amino acid substitution ORF7a:P45L in the Delta isolates found to be significantly associated with disease severity. In conclusion, this study evidenced that Identified novel substitutions Nsp13: A85P and Nsp12: Y479N, have a destabilizing effect, while missense substitution ORF7a: P45L significantly associated with disease severity. |
format | Online Article Text |
id | pubmed-9236271 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-92362712022-06-28 Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan Abdullaev, Alisher Abdurakhimov, Abrorjon Mirakbarova, Zebinisa Ibragimova, Shakhnoza Tsoy, Vladimir Nuriddinov, Sharofiddin Dalimova, Dilbar Turdikulova, Shahlo Abdurakhmonov, Ibrokhim PLoS One Research Article Tracking temporal and spatial genomic changes and evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are among the most urgent research topics worldwide, which help to elucidate the coronavirus disease 2019 (COVID-19) pathogenesis and the effect of deleterious variants. Our current study concentrates genetic diversity of SARS-CoV-2 variants in Uzbekistan and their associations with COVID-19 severity. Thirty-nine whole genome sequences (WGS) of SARS-CoV-2 isolated from PCR-positive patients from Tashkent, Uzbekistan for the period of July-August 2021, were generated and further subjected to further genomic analysis. Genome-wide annotations of clinical isolates from our study have revealed a total of 223 nucleotide-level variations including SNPs and 34 deletions at different positions throughout the entire genome of SARS-CoV-2. These changes included two novel mutations at the Nonstructural protein (Nsp) 13: A85P and Nsp12: Y479N, which were unreported previously. There were two groups of co-occurred substitution patterns: the missense mutations in the Spike (S): D614G, Open Reading Frame (ORF) 1b: P314L, Nsp3: F924, 5`UTR:C241T; Nsp3:P2046L and Nsp3:P2287S, and the synonymous mutations in the Nsp4:D2907 (C8986T), Nsp6:T3646A and Nsp14:A1918V regions, respectively. The “Nextstrain” clustered the largest number of SARS-CoV-2 strains into the Delta clade (n = 32; 82%), followed by two Alpha-originated (n = 4; 10,3%) and 20A (n = 3; 7,7%) clades. Geographically the Delta clade sample sequences were grouped into several clusters with the SARS-CoV genotypes from Russia, Denmark, USA, Egypt and Bangladesh. Phylogenetically, the Delta isolates in our study belong to the two main subclades 21A (56%) and 21J (44%). We found that females were more affected by 21A, whereas males by 21J variant (χ2 = 4.57; p ≤ 0.05, n = 32). The amino acid substitution ORF7a:P45L in the Delta isolates found to be significantly associated with disease severity. In conclusion, this study evidenced that Identified novel substitutions Nsp13: A85P and Nsp12: Y479N, have a destabilizing effect, while missense substitution ORF7a: P45L significantly associated with disease severity. Public Library of Science 2022-06-27 /pmc/articles/PMC9236271/ /pubmed/35759503 http://dx.doi.org/10.1371/journal.pone.0270314 Text en © 2022 Abdullaev et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Abdullaev, Alisher Abdurakhimov, Abrorjon Mirakbarova, Zebinisa Ibragimova, Shakhnoza Tsoy, Vladimir Nuriddinov, Sharofiddin Dalimova, Dilbar Turdikulova, Shahlo Abdurakhmonov, Ibrokhim Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan |
title | Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan |
title_full | Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan |
title_fullStr | Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan |
title_full_unstemmed | Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan |
title_short | Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan |
title_sort | genome sequence diversity of sars-cov-2 obtained from clinical samples in uzbekistan |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236271/ https://www.ncbi.nlm.nih.gov/pubmed/35759503 http://dx.doi.org/10.1371/journal.pone.0270314 |
work_keys_str_mv | AT abdullaevalisher genomesequencediversityofsarscov2obtainedfromclinicalsamplesinuzbekistan AT abdurakhimovabrorjon genomesequencediversityofsarscov2obtainedfromclinicalsamplesinuzbekistan AT mirakbarovazebinisa genomesequencediversityofsarscov2obtainedfromclinicalsamplesinuzbekistan AT ibragimovashakhnoza genomesequencediversityofsarscov2obtainedfromclinicalsamplesinuzbekistan AT tsoyvladimir genomesequencediversityofsarscov2obtainedfromclinicalsamplesinuzbekistan AT nuriddinovsharofiddin genomesequencediversityofsarscov2obtainedfromclinicalsamplesinuzbekistan AT dalimovadilbar genomesequencediversityofsarscov2obtainedfromclinicalsamplesinuzbekistan AT turdikulovashahlo genomesequencediversityofsarscov2obtainedfromclinicalsamplesinuzbekistan AT abdurakhmonovibrokhim genomesequencediversityofsarscov2obtainedfromclinicalsamplesinuzbekistan |